Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Julija Filipovska

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Methods in Molecular Medicine|April 22, 2003
Opioid receptor oligomerization. Detection and functional characterization of interacting receptorsIvone Gomes, Julija Filipovska, Lakshmi A Devi
Frontiers in Public Health|August 28, 2023
CIAO: a living experiment in interdisciplinary large-scale collaboration facilitated by the Adverse Outcome Pathway frameworkAnnamaria Carusi, Julija Filipovska, Clemens Wittwehr, et al.
Methods (San Diego, Calif.)|September 10, 2002
Oligomerization of opioid receptorsIvone Gomes, Julija Filipovska, Bryen A Jordan, et al.
The Australian Journal of Rural Health|March 6, 2008
An evaluation of a community pharmacy-based rural asthma management serviceBandana Saini, Julija Filipovska, Sinthia Bosnic-Anticevich, et al.
Methods in Molecular Medicine|April 22, 2003
Recombinant opioid receptors. Structure-function relationshipJulija Filipovska, Ivone Gomes, Wei Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 27, 2004
A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesiaIvone Gomes, Achla Gupta, Julija Filipovska, et al.
ALTEX|November 19, 2023
Beyond chemicals: Opportunities and challenges of integrating non-chemical stressors in adverse outcome pathwaysLaure-Alix Clerbaux, Julija Filipovska, Penny Nymark, et al.
Neurotoxicology|May 19, 2024
A systematic scoping review of the neurological effects of COVID-19Helena T Hogberg, Katya Tsaioun, Joshua D Breidenbach, et al.
F1000Research|May 11, 2026
Methods2AOP: A Collaboration to Strengthen the Integration of Test Methods into the Adverse Outcome Pathway FrameworkAgnes L Karmaus, William Bisson, Albert Braeuning, et al.
Environmental Toxicology and Chemistry|July 8, 2025
Adverse Outcome Pathway (AOP) Coaching Program-How it functions and contributes to a more harmonized approach to AOP development and construction of AOP networks with regulatory utilityShihori Tanabe, Tanja Burgdorf, Judy Choi, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Methods in Molecular Medicine|April 22, 2003
Opioid receptor oligomerization. Detection and functional characterization of interacting receptorsIvone Gomes, Julija Filipovska, Lakshmi A Devi
Frontiers in Public Health|August 28, 2023
CIAO: a living experiment in interdisciplinary large-scale collaboration facilitated by the Adverse Outcome Pathway frameworkAnnamaria Carusi, Julija Filipovska, Clemens Wittwehr, et al.
Methods (San Diego, Calif.)|September 10, 2002
Oligomerization of opioid receptorsIvone Gomes, Julija Filipovska, Bryen A Jordan, et al.
The Australian Journal of Rural Health|March 6, 2008
An evaluation of a community pharmacy-based rural asthma management serviceBandana Saini, Julija Filipovska, Sinthia Bosnic-Anticevich, et al.
Methods in Molecular Medicine|April 22, 2003
Recombinant opioid receptors. Structure-function relationshipJulija Filipovska, Ivone Gomes, Wei Xu, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 27, 2004
A role for heterodimerization of mu and delta opiate receptors in enhancing morphine analgesiaIvone Gomes, Achla Gupta, Julija Filipovska, et al.
ALTEX|November 19, 2023
Beyond chemicals: Opportunities and challenges of integrating non-chemical stressors in adverse outcome pathwaysLaure-Alix Clerbaux, Julija Filipovska, Penny Nymark, et al.
Neurotoxicology|May 19, 2024
A systematic scoping review of the neurological effects of COVID-19Helena T Hogberg, Katya Tsaioun, Joshua D Breidenbach, et al.
F1000Research|May 11, 2026
Methods2AOP: A Collaboration to Strengthen the Integration of Test Methods into the Adverse Outcome Pathway FrameworkAgnes L Karmaus, William Bisson, Albert Braeuning, et al.
Environmental Toxicology and Chemistry|July 8, 2025
Adverse Outcome Pathway (AOP) Coaching Program-How it functions and contributes to a more harmonized approach to AOP development and construction of AOP networks with regulatory utilityShihori Tanabe, Tanja Burgdorf, Judy Choi, et al.
Pageof 2